Menu

An exterior shot of HHS building.

CMS has announced that the 13 drugmakers selected for the Medicare Drug Price Negotiation Program’s 2028 cycle signed agreements, initiating the negotiation period with the agency.

Drugmakers Agree to Take Part in Third Round of IRA’s Medicare Drug Price Talks, New Drugs Added to TrumpRx

March 17, 2026 Shannon Young, Associate Editor/Senior Writer 340B Report Views

The manufacturers behind the 15 Medicare Part D and—for the first time—Part B drugs chosen for the third round of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Texas Hospital Again Sues HHS Over IPPS Rule After Appeals Court Overturned Ruling Blocking It

340B Expected to Play Key Role in Tomorrow’s House Hearing, With One Witness Calling to ‘Replace’ Program